circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family

Leemans CR, Braakhuis BJM, Brakenhoff RH . The molecular biology of head and neck cancer. Nat Rev Cancer 2010; 11: 9–22.

Siegel R, Ward E, Brawley O, Jemal A . Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212–236.

Beenken SW, Urist MM Head and neck tumors. In: Way LW, Doherty GM (eds). Current Surgical Diagnosis and Treatment. 11th edn. Lange Medical Books/McGraw-Hill: New York, 2003, pp 282–297.

La Vecchia C, Lucchini F, Negri E, Levi F . Trends in oral cancer mortality in Europe. Oral Oncol 2004; 40: 433–439.

Massano J, Regateiro FS, Januário G, Ferreira A . Oral squamous cell carcinoma: Review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 67–76.

Singh SK, Pal Bhadra M, Girschick HJ, Bhadra U . MicroRNAs-micro in size but macro in function. FEBS J 2008; 275: 4929–4944.

Zhang B, Pan X, Cobb GP, Anderson TA . microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1–12.

Fatica A, Bozzoni I . Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 2014; 15: 7–21.

Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, Riccio A et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci USA 2008; 105: 12417–12422.

Gomes CC, Gomez RS . MicroRNA and oral cancer: Future perspectives. Oral Oncol 2008; 44: 910–914.

Esquela-Kerscher A, Slack FJ . Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259–269.

Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J . Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008; 68: 2094–2105.

Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS, Chang KW . miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol 2010; 46: 204–208.

Reis PP, Tomenson M, Cervigne NK, Machado J, Jurisica I, Pintilie M et al. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer 2010; 9: 1–13.

Tang H, Wu Z, Zhang J, Su B . Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep 2013; 7: 761–766.

Fang Z, Wu L, Wang L, Yang Y, Meng Y, Yang H . Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2014; 117: 89–95.

Jia LF, Wei SB, Gan YH, Guo Y, Gong K, Mitchelson K et al. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. Int J Cancer 2014; 135: 2282–2293.

Jeck WR, Sharpless NE . Detecting and characterizing circular RNAs. Nat Biotechnol 2014; 32: 453–461.

Lasda E, Parker R . Circular RNAs: diversity of form and function. RNA 2014; 20: 1829–1842.

Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 2015; 25: 981–984.

Hentze MW, Preiss T . Circular RNAs: splicing’s enigma variations. EMBO J 2013; 32: 923–925.

Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013; 495: 333–338.

Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013; 19: 141–157.

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011; 146: 353–358.

Guo JU, Agarwal V, Guo H, Bartel DP . Expanded identification and characterization of mammalian circular RNAs. Genome Biol 2014; 15: 409.

Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011; 147: 344–357.

Karreth FA, Tay Y, Perna D, Ala U, Tan SM, Rust AG et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011; 147: 382–395.

Sumazin P, Yang X, Chiu HS, Chung WJ, Iyer A, Llobet-Navas D et al. An extensive microRNA-mediated network of RNA–RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 2011; 147: 370–381.

Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147: 358–369.

Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK et al. Natural RNA circles function as efficient microRNA sponges. Nature 2013; 495: 384–388.

Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun 2016; 7: 11215.

Cole AM, Myant K, Reed KR, Ridgway RA, Athineos D, Van den Brink GR et al. Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss. Cancer Res 2010; 70: 8149–8158.

Kollmann K, Heller G, Schneckenleithner C, Warsch W, Scheicher R, Ott RG et al. A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell 2013; 24: 167–181.

Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129: 1401–1414.

Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834–838.

Ebert MS, Neilson JR, Sharp PA . MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007; 4: 721–726.

Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP . A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010; 465: 1033–1038.

Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010; 38: 5366–5383.

Lee DY, Jeyapalan Z, Fang L, Yang J, Zhang Y, Yee AY et al. Expression of versican 3′-untranslated region modulates endogenous microRNA functions. PLoS One 2010; 5: e13599.

Jeyapalan Z, Deng Z, Shatseva T, Fang L, He C, Yang BB . Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res 2011; 39: 3026–3041.

Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 2013; 25: 69–80.

Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y et al. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis 2014; 5: e1287.

Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013; 52: 101–112.

Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer 2014; 13: 92.

Ma MZ, Li CX, Zhang Y, Weng MZ, Zhang MD, Qin YY et al. Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer. Mol Cancer 2014; 13: 156.

Wang K, Long B, Zhou LY, Liu F, Zhou QY, Liu CY et al. CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat Commun 2014; 5: 3596.

Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014; 25: 666–681.

Guo G, Kang Q, Zhu X, Chen Q, Wang X, Chen Y et al. A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA. Oncogene 2015; 34: 1768–1779.

Hsu MT, Coca-Prados M . Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature 1979; 280: 339–340.

Arnberg AC, van Ommen GJ, Grivell LA, van Bruggen EF, Borst P . Some yeast mitochondrial RNAs are circular. Cell 1980; 19: 313–319.

Cocquerelle C, Mascrez B, Hetuin D, Bailleul B . Missplicing yields circular RNA molecules. FASEB J 1993; 7: 155–160.

Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO . Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PloS One 2012; 7: e30733.

Li P, Chen S, Chen H, Mo X, Li T, Shao Y et al. Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clin Chim Acta 2015; 444: 132–136.

Tay Y, Rinn J, Pandolfi PP . The multilayered complexity of ceRNA crosstalk and competition. Nature 2014; 505: 344–352.

Mott JL, Kobayashi S, Bronk SF, Gores GJ . mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007; 26: 6133–6140.

Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA 2008; 105: 5874–5878.

Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3 A and 3B and indirectly DNMT1. Blood 2009; 113: 6411–6418.

Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and3B. Proc Natl Acad Sci USA 2007; 104: 15805–15810.

Ding DP, Chen ZL, Zhao XH, Wang JW, Sun J, Wang Z et al. miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression. Carcinogenesis 2011; 32: 1025–1032.

Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W et al. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010; 115: 2630–2639.

Rivadeneira DB, Mayhew CN, Thangavel C, Sotillo E, Reed CA, Graña X et al. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells. Gastroenterology 2010; 138: 1920–1930.